ArticlePloS one2025
Cross-ViT based benign and malignant classification of pulmonary nodules.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DPCrossU-Net: a dual-branch parallel CNN-Transformer network for lung nodule segmentation.Frontiers in oncology · 2026Article
- Deep learning for Three-Class Classification of ground-glass nodules on non-enhanced chest CT: A multicenter comparative study of CNN architectures.European journal of radiology open · 2025Article
- The Impact of Artificial Intelligence on Lung Cancer Diagnosis and Personalized Treatment.International journal of molecular sciences · 2025Review
- Applications and challenges of multi-omics approaches in lung cancer research and precision treatment.Frontiers in genetics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The benign and malignant discrimination of pulmonary nodules plays a very important role in diagnosing the extent of lung cancer lesions. There are many methods using Convolutional neural network (CNN) for benign and malignant classification of pulmonary nodules, but traditional CNN models focus more on the local features of pulmonary nodules and lack the extraction of global features of pulmonary nodules. To solve this problem, a Cross fusion attention ViT (Cross-ViT) network that fuses local features extracted by CNN and global features extracted by Transformer is proposed. The network first extracts different features independently through two branches and then performs feature fusion through the Cross fusion attention module. Cross-ViT can effectively capture and process both local and global information of lung nodules, which improves the accuracy of classifying the benign and malignant nature of pulmonary nodules. Experimental validation was performed on the LUNA16 dataset, and the accuracy, precision, recall and F1 score reached 91.04%, 91.42%, 92.45% and 91.92%, respectively, and the accuracy, precision, recall and F1 score with SENet as CNN branch reached 92.43%, 94.27%, 91.68% and 92.96%, respectively. The results show that the accuracy, precision, recall and F1 score of the proposed method are 0.3%, 0.11%, 4.52% and 3.03% higher than those of the average optimal method, respectively, and the performance of Cross-ViT network for benign and malignant classification is better than most classification methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.